South Australian Trends in Ecstasy and Related Drug Markets 2012

📖 The Scoop

This report presents the findings from the twelfth year in which data has been collected in South Australia. The Ecstasy and Related Drugs Reporting System (EDRS; formerly the Party Drugs Initiative, or PDI), monitors the price, purity and availability of ecstasy (MDMA) and other drugs such as methamphetamine, cocaine, gamma-hydroxybutyrate (GHB), d-lysergic acid (LSD), 3,4-methylendioxyamphetamine (MDA) and ketamine. It also examines the demographic characteristics and patterns of drug use among regular ecstasy users (REU), the prevalence of risk-taking and harms related to drug use, as well as the level of criminal involvement among this group. It utilises data from three sources: (a) surveys with regular ecstasy users (REU); (b) surveys with key experts (KE) who have contact with REU through the nature of their work; and (c) the analysis of existing data sources that contain information on ecstasy and related drugs (ERD). The EDRS surveys are not representative of ecstasy and other drug users in the general population. The REU are a sentinel group that provides information on patterns of drug use and market trends.

Genre: Medical / General (fancy, right?)